Lapatinib Abnib 250mg 30 Tablet
Lapatinib Abnib 250mg 30 Tablet

Lapatinib Abnib 250mg 30 Tablet

MOQ : 10 Pieces

Lapatinib Abnib 250mg 30 Tablet Specification

  • Salt Composition
  • Lapatinib I.P. 250mg
  • Packaging Type
  • Box
  • Life Span
  • Check expiry on label
  • Indication
  • HER2-positive breast cancer
  • Brand Name
  • Abnib
  • Origin of Medicine
  • India
  • Pacakaging (Quantity Per Box)
  • 30 Tablets
  • Dosage Form
  • Tablet
  • Drug Type
  • Prescription (Rx)
  • Ingredients
  • Lapatinib
  • Physical Form
  • Tablet
  • Function
  • Antineoplastic, targeted therapy for cancer
  • Recommended For
  • Breast Cancer Patients; as prescribed by doctor
  • Dosage
  • As directed by the physician
  • Dosage Guidelines
  • Follow physicians advice, usually once daily
  • Suitable For
  • Adults
  • Quantity
  • 30 Tablets
  • Storage Instructions
  • Store below 30C, away from moisture and sunlight
  • Prescription Required
  • Yes
  • Administration Route
  • Oral
  • Strength
  • 250 mg per tablet
  • Appearance
  • Box containing blister packs
  • Warning
  • Keep out of reach of children
  • Contraindication
  • Known hypersensitivity to Lapatinib or any tablet component
  • Side Effects
  • Nausea, diarrhea, rash, fatigue (consult leaflet/doctor)
  • Therapeutic Class
  • Anticancer
  • Market Availability
  • Exported to Canada, Europe, UK, USA, Australia
 
 

About Lapatinib Abnib 250mg 30 Tablet



Capitalise on the elite therapeutic power of Lapatinib Abnib 250mg, a breathtaking, best-seller anticancer medicine. This valiant oral targeted therapy, sourced from India and exported worldwide, targets HER2-positive breast cancer with precision. Each box contains 30 film-coated tablets, ensuring optimal dosing convenience. Price Cut offers make it highly accessible for patients seeking high-impact therapy. Only available by prescription, Lapatinib Abnib prioritises safety-warnings, contraindications, and potential side effects are clearly stated. Rely on Abnib, a trusted name in targeted cancer care, to empower treatment outcomes.

Elite Targeted Therapy for Breast Cancer

Lapatinib Abnib 250mg is expertly used to treat HER2-positive breast cancer in adults, adhering strictly to a physician's prescription. Its antineoplastic action disrupts cancer growth through a targeted mechanism, providing a valiant option for those in need. This oral tablet must be taken as advised, offering convenient daily dosing. Composed of premium Lapatinib I.P., Abnib stands as a globally recognised elite solution for patients requiring focused, high-efficacy anticancer treatment.


Packaging & Availability - Swift Order Processing

Lapatinib Abnib 250mg comes in a robust, tamper-evident box containing 30 tablets, each securely sealed in blister packs. Stock is ready for immediate order processing, ensuring minimal wait times for international clients across Canada, Europe, Australia, the UK, and the USA. Certified for export quality, each batch undergoes strict compliance checks. Multiple delivery channels support efficient export, enhancing availability in the main domestic and international markets.


FAQ's of Lapatinib Abnib 250mg 30 Tablet:


Q: How should Lapatinib Abnib 250mg be taken for best results?

A: Lapatinib Abnib 250mg should be taken orally, once daily, as directed by your physician. Consistency in timing and adherence to prescribed dosage are crucial for optimal therapeutic effect.

Q: What is the main benefit of Lapatinib Abnib 250mg in cancer treatment?

A: Lapatinib Abnib 250mg offers targeted therapy for HER2-positive breast cancer, disrupting cancer cell growth and improving patient outcomes through a focused antineoplastic approach.

Q: When is Lapatinib Abnib 250mg contraindicated?

A: This medication should not be used by individuals with known hypersensitivity to Lapatinib or any component of the tablet. Always consult your doctor regarding suitability for your condition.

Q: Where is Lapatinib Abnib 250mg available for export?

A: Lapatinib Abnib is exported to Canada, Europe, the UK, USA, and Australia, ensuring broad international accessibility for patients and healthcare providers.

Q: What should patients do if they experience side effects from Lapatinib Abnib?

A: If you experience side effects such as nausea, diarrhea, rash, or fatigue, consult your physician or refer to the provided leaflet for guidance and management options.

Q: How is Lapatinib Abnib 250mg packaged for delivery?

A: Each box of Lapatinib Abnib contains 30 tablets, individually sealed in blister packs to maintain quality during stock storage, order processing, and international shipping.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Oncology Medicine Category

Gliotem Temozolomide 100mg capsule

Gliotem Temozolomide 100mg capsule

Minimum Order Quantity : 10 Pieces

Life Span : Check expiry date on package; typically 23 years from manufacture

Packaging Type : Blister pack

Salt Composition : Temozolomide 100mg

Quantity : 5 Capsules per strip

Ingredients : Temozolomide

Barijak Baricitinib 4mg Tablets

Barijak Baricitinib 4mg Tablets

Minimum Order Quantity : 10 Pieces

Life Span : Refer to packaging for expiry date

Packaging Type : Box

Salt Composition : Baricitinib 4 mg

Quantity : 14 Tablets

Ingredients : Baricitinib

Stivarga Regorafenib 40 Mg Tablet

Stivarga Regorafenib 40 Mg Tablet

Minimum Order Quantity : 10 Pieces

Life Span : Check expiry date on packaging

Packaging Type : Box/Blister pack

Salt Composition : Regorafenib 40 mg

Quantity : 28 tablets per box

Ingredients : Regorafenib

Lapatinib Etibo 250mg 30 Tablet

Lapatinib Etibo 250mg 30 Tablet

Minimum Order Quantity : 10 Pieces

Life Span : Check strip/box for expiry date

Packaging Type : Box

Salt Composition : Lapatinib

Quantity : 30 Tablets

Ingredients : Lapatinib



Back to top